NIHON KOHDEN CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,795 JPY | +3.07% |
|
+4.40% | +7.44% |
| Sales 2024 | 222B 1.41B | Sales 2025 * | 231B 1.47B | Capitalization | 402B 2.56B |
|---|---|---|---|---|---|
| Net income 2024 | 17.03B 108M | Net income 2025 * | 16.1B 102M | EV / Sales 2024 | 1.29 x |
| Net cash position 2024 | 49.85B 317M | Net cash position 2025 * | 45.62B 290M | EV / Sales 2025 * | 1.54 x |
| P/E ratio 2024 |
19.8
x | P/E ratio 2025 * |
24.6
x | Employees | 5,751 |
| Yield 2024 |
1.52% | Yield 2025 * |
1.29% | Free-Float | 94.59% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +3.07% | ||
| 1 week | +4.40% | ||
| 1 month | +11.51% | ||
| 3 months | +15.71% | ||
| 6 months | +29.18% | ||
| Current year | +7.44% |
1 week
4 514.00
4 819.00
1 month
4 202.004 819.00
Current year
3 810.004 819.00
1 year
3 372.004 819.00
3 years
2 762.004 819.00
5 years
2 556.004 819.00
10 years
1 914.004 819.00
| Managers | Title | Age | Since |
|---|---|---|---|
Hirokazu Ogino
CEO | Chief Executive Officer | 54 | 95-03-31 |
Hiroyuki Satake
CTO | Chief Tech/Sci/R&D Officer | - | 84-03-31 |
Tadashi Hasegawa
ADM | Chief Administrative Officer | 65 | 14-03-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 72 | 16-05-31 | |
Hidemitsu Sasaya
BRD | Director/Board Member | 71 | 22-05-31 |
Eiichi Tanaka
BRD | Director/Board Member | 61 | 85-03-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.32% | 17 M€ | +4.62% | ||
| 0.28% | 32 M€ | +15.69% | ||
| 0.13% | 4 M€ | +19.76% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-31 | 4,795 | +3.07% | 357,300 |
| 24-05-30 | 4,652 | +2.33% | 296,100 |
| 24-05-29 | 4,546 | -1.84% | 266,200 |
| 24-05-28 | 4,631 | +0.41% | 169,700 |
| 24-05-27 | 4,612 | +0.41% | 249,200 |
Delayed Quote Japan Exchange, May 31, 2024 at 02:00 am EDT
More quotes
NIHON KOHDEN CORPORATION is a Japan-based company engaged in the research, development, manufacture and sale of medical electronic equipment, as well as the provision of maintenance and repair services. The Company mainly operates medical electronics related business. The Company offers electroencephalograph, electromyographic, evoked potential testing equipment, electrocardiographs, cardiac catheterization equipment, diagnostic information systems and related consumables (paper, electrodes, catheters and others), biological information monitors, clinical information systems, artificial respiration, artificial ear, hemocytometer, ultrasonic diagnostic equipment, research equipment and transformers, among others. The Company is also engaged in the sales promotion for its products, as well as the general affair-related and manpower dispatching businesses.
Calendar
2024-06-26
- Split: 2 of 1
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
HOLD
Number of Analysts
6
Last Close Price
4,795
JPY
Average target price
4,456
JPY
Spread / Average Target
-7.07%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +7.44% | 2.56B | |
| +7.01% | 217B | |
| +11.01% | 190B | |
| +19.20% | 143B | |
| +30.79% | 111B | |
| +1.48% | 64.59B | |
| +13.95% | 52.36B | |
| -0.16% | 48.45B | |
| -6.20% | 38.03B | |
| +0.91% | 35.61B |
- Stock Market
- Equities
- 6849 Stock
